Your English writing platform
Discover LudwigSimilar(60)
The findings may serve as good starting points for the development of more potent EPAC antagonists as valuable pharmacological probes or potential drug candidates.
Alternatively, novel small peptides that block calcineurin/NFAT interaction without inhibiting calcineurin phosphatase activity have exhibited efficacy for inhibiting NFAT in vivo in the absence of significant toxicity (Yu et al, 2007) and may prove to be valuable as therapeutic NFAT antagonists.
This study supports the idea that both PAR2 agonists and antagonists might have valuable therapeutic roles in different tissues and encourages the development of both agonists and especially antagonists that are selective for PAR2 as potential new therapies for cancers and inflammatory conditions.
Thus, 5-HT2B receptor antagonists represent a valuable novel therapeutic approach for RVF.
Valuable, I mean.
For these patients methylnaltrexone, a peripherally acting μ-opioid receptor antagonist, can be a valuable therapeutic option.
Ultimately, we do not face well-meaning, but ignorant antagonists who incidentally damage valuable work.
Significantly, the venom exhibited inhibitory effects on TTX-R Na+ and T-type Ca2+ currents, suggesting that there exist both channel antagonists which might be valuable tools for investigation of both channels and drug development.
Abrogation of the protective effect of p53 antagonists would provide a valuable target for tumor therapy, especially since relatively non toxic molecules such as Qct can affect its translocation and activity.
The prediction model is a valuable tool for designing a novel AR antagonist.
This property of ILEs is more valuable in those situations where calcium channel antagonist toxicity is prevailing [ 35, 44, 45].
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com